1.Date of occurrence of the event:2024/02/29

2.Company name:TSH Biohparm Corporation Limited

3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office

4.Reciprocal shareholding ratios:N/A

5.Cause of occurrence:
The Company acquired 51.6% of the shares in Chuang Yi Biotech Co., Ltd. on November 24, 2023. Holding more than 50% of shares represents control over Chuang Yi Biotech Co., Ltd. Pursuant to the Interpretation (2012) No.301 issued by the Accounting Research and Development Foundation, such transaction was classified as reorganization under common control,and it shall be considered that combination had taken place at the beginning of the comparative period. Therefore, restate both monthly and accumulated sales revenue from January to November in 2023 and 2022.

6.Information items/ statements to be corrected:Monthly sales revenue and accumulated sales revenue

7.Amounts/ contents/ number of page to be corrected:(In thousands)
January 2023/ Monthly sales:41,308 Accumulated sales:41,308
February 2023/ Monthly sales:34,638 Accumulated sales:75,946
March 2023/ Monthly sales:41,516 Accumulated sales:117,462
April 2023/ Monthly sales:39,677 Accumulated sales:157,139
May 2023/ Monthly sales:42,254 Accumulated sales:199,393
June 2023/ Monthly sales:44,772 Accumulated sales:244,165
July 2023/ Monthly sales:40,410 Accumulated sales:284,576
August 2023/ Monthly sales:40,829 Accumulated sales:325,405
September 2023/ Monthly sales:42,469 Accumulated sales:367,874
October 2023/ Monthly sales:41,707 Accumulated sales:409,581
November 2023/Monthly sales:43,490 Accumulated sales:453,071

8.Amounts/ contents/ number of page after correction:(In thousands)
January 2023/ Monthly sales:47,718 Accumulated sales:47,718
February 2023/ Monthly sales:44,700 Accumulated sales:92,418
March 2023/ Monthly sales:52,440 Accumulated sales:144,858
April 2023/ Monthly sales:48,177 Accumulated sales:193,035
May 2023/ Monthly sales:54,992 Accumulated sales:248,027
June 2023/ Monthly sales:67,111 Accumulated sales:315,138
July 2023/ Monthly sales:48,507 Accumulated sales:363,644
August 2023/ Monthly sales:60,997 Accumulated sales:424,641
September 2023/ Monthly sales:159,916 Accumulated sales:584,557
October 2023/ Monthly sales:90,838 Accumulated sales:675,396
November 2023/ Monthly sales:63,687 Accumulated sales:739,083

9.Countermeasures:Correct the Company's monthly sales revenue and accumulated sales revenue from January to November in 2023 and 2022.

10.Any other matters that need to be specified:None.